Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY Study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild hyperthermia (a form of heat therapy) for treating recurrent chest wall breast cancer. Related posts Array [...]
ThermoDox's tag archives
Rhode Island Hospital First in Country to Enroll Patient in New National Study for Treating Recurrent Chest Wall Breast Cancer
Posted by Dana in July 21st 2009
Recent Articles
-
- Vertex Pharmaceuticals Reports Second Quarter 2010 Financial Results and Highlights Recent Business and Clinical Progress
- AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
- CardioNet, Inc. Reports Second Quarter 2010 Financial Results
- NPS Pharmaceuticals to Report Second Quarter 2010 Financial Results
- BioAlliance Pharma SA: A Record Turnover for Q2 2010 Reflecting the Successful US FDA Approval
- HealthStream Announces Second Quarter 2010 Results
- Simulations Plus Reports Third Quarter FY2010 Financial Results
- ZOLL Medical Corporation to Announce Third Quarter Results
- AngioDynamics Reports Strong Finish to Fiscal 2010
- Cubist Pharmaceuticals 2Q10 Total Net Revenues Up 29% to $168.5 Million
- Furiex Pharmaceuticals Announces Second Quarter 2010 Earnings Release and Conference Call
- Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2010
- Biomet Announces Fourth Quarter and Fiscal Year 2010 Financial Results
- Allergan Announces Quarterly Conference Call
- Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010
